Biological consequences of the BCR/ABL fusion gene in humans and mice
about
Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - clinical benefits.Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.
P2860
Biological consequences of the BCR/ABL fusion gene in humans and mice
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Biological consequences of the BCR/ABL fusion gene in humans and mice
@ast
Biological consequences of the BCR/ABL fusion gene in humans and mice
@en
type
label
Biological consequences of the BCR/ABL fusion gene in humans and mice
@ast
Biological consequences of the BCR/ABL fusion gene in humans and mice
@en
prefLabel
Biological consequences of the BCR/ABL fusion gene in humans and mice
@ast
Biological consequences of the BCR/ABL fusion gene in humans and mice
@en
P2860
P356
P1476
Biological consequences of the BCR/ABL fusion gene in humans and mice
@en
P2093
P2860
P304
P356
10.1136/JCP.52.10.719
P407
P577
1999-10-01T00:00:00Z